Monthly Archives: November 2009

Conflicts galore among critics of new mammography guidelines

Share This Wednesday, the House Committee on Energy and Commerce will hold a hearing on the new breast cancer screening recommendations, in response no doubt to the storm of criticism that greeted the recent guidelines issued by the US Preventative … Continue reading

Posted in Uncategorized | 2 Comments

New study finds link between TV ads and higher drug prices

Share We’ve got family coming in for Thanksgiving and I have much to do. So this week, I’d just like to point my faithful readers to three items of interest: 1. Gary Schwitzer’s great blog, which goes a long way … Continue reading

Posted in Uncategorized | Leave a comment

A solution to the problem of scientific misconduct?

Share Talk about synergy. Just a few days ago, my health and science journalism class at Brandeis was discussing ethics in science, using as a template an old case example involving scientific fraud in the University of Michigan laboratory then … Continue reading

Posted in Uncategorized | 1 Comment

Was the Fort Hood shooter taking antidepressants?

Share In the days since the Fort Hood shooting, I have wondered whether the gunman, Major Nidal Malik Hasan, was taking antidepressants in the weeks or months before he sprayed a medical clinic with bullets, killing 13 people. I hesitated … Continue reading

Posted in Uncategorized | 6 Comments

Amgen and Aranesp: One more example of how drug companies make huge profits by misleading consumers

Share Just in case you didn’t read the Saturday papers, let me call your attention to this article in The Boston Globe about the chickens coming home to roost for Amgen, the California biotech that makes Aranesp, an anti-anemia drug … Continue reading

Posted in Uncategorized | 2 Comments